Navigation Links
MRI Can Spot Presymptomatic MS
Date:12/10/2008

A third of patients with suspect scans develop the disease within 5 years, study finds

WEDNESDAY, Dec. 10 (HealthDay News) -- Among people whose brain scans show signs of multiple sclerosis but who have no symptoms, one-third will develop MS within about five years, researchers say.

The study included 44 people who had MRI brain scans for a variety of reasons, including migraines or head trauma. The scans detected abnormalities similar to those that occur in MS. After the researchers confirmed these abnormalities were MS-related and ruled out other causes, they followed the patients for a number of years to find out if they developed the disease.

After an average of 5.4 years, 30 percent of the patients had developed MS symptoms. Brain scans showed that another 29 percent of patients had further abnormalities but still showed no symptoms.

"More research is needed to fully understand the risk of developing MS for people with these brain abnormalities, but it appears that this condition may be a precursor to MS," study author Dr. Darin T. Okuda, of the University of California, San Francisco, Medical Center, said in an American Academy of Neurology news release.

Okuda and colleagues, who labeled this condition "radiologically isolated syndrome" (RIS), said further research is needed before any recommendations can be made regarding treatment.

The study was published online Wednesday in the journal Neurology.

In an accompanying editorial, Dr. Dennis Bourdette of the Oregon Health & Science University in Portland noted that seven of the study participants had received MS treatment before they were referred to the UCSF MS center.

"Diagnosing a patient with MS has serious psychosocial and treatment implications, and physicians have an obligation to follow appropriate criteria in making the diagnosis," Bourdette wrote. "Patients must have symptoms to receive a diagnosis. This study sets the stage for establishing a process for evaluating these patients and following them to help determine the risk of developing MS. Until then, we should not tell them that they have MS or treat them with disease-modifying therapies. For now, it's best to remember the wise advice that we treat the patient, not the MRI scan."

More information

The National Multiple Sclerosis Society has more about diagnosing MS.



-- Robert Preidt



SOURCE: American Academy of Neurology, news release, Dec. 10, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
MRI Can Spot Presymptomatic MS
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Grove Investment Group (TGIG), has initiated cultivation and processing operations at its production ... and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: